MedPath

Minimum Current for Train-of-four Monitoring

Not Applicable
Completed
Conditions
Anesthesia Recovery Period
Anesthesia
Neuromuscular Blockade
Registration Number
NCT04581720
Lead Sponsor
Ewha Womans University Mokdong Hospital
Brief Summary

Neuromuscular monitoring during general anesthesia is important to make sure adequate muscle relaxation during operation and adequate recovery of muscle power and spontaneous breathing during emergence from general anesthesia. The neuromuscular monitoring is usually using electrical stimulants and the method called train-of-four (TOF) is representative. Because it uses electrical stimulants, the patients could be uncomfortable and feel pain during the monitoring when the patients are conscious. Lowering the current of the stimulants would be helpful in reducing the pain, but there is a concern that the TOF results performed in lower current would be underestimated or inaccurate. Therefore, the investigators want to find the minimal current for TOF monitoring that shows adequate TOF results.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Age 20-65
  • Scheduled for an elective surgery
  • ASA physical status 1 or 2
Exclusion Criteria
  • BMI > 25 kg/m2
  • Neuromuscular disease
  • Decreased renal function
  • Neurologic disorder
  • Impossible to cooperate or communicate

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Minimal current for TOFDuring the operation, from the height of T1 reaches back to the baseline, to the extubation of tracheal tube when the general anesthesia is over.

The minimal current among the four currents we use which is showing not significantly lower TOF ratio than TOF ratio of supramaximal stimulant.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ewha Womans University Mokdong Hospital

🇰🇷

Seoul, Korea, Republic of

Ewha Womans University Mokdong Hospital
🇰🇷Seoul, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.